- Home
- PTGX vs PFS Comparison
PTGX vs PFS Comparison
Compare PTGX & PFS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PTGX
- PFS
- Stock Information
- Founded
- PTGX 2006
- PFS 1839
- Country
- PTGX United States
- PFS United States
- Employees
- PTGX N/A
- PFS N/A
- Industry
- PTGX Biotechnology: Pharmaceutical Preparations
- PFS Savings Institutions
- Sector
- PTGX Health Care
- PFS Finance
- Exchange
- PTGX Nasdaq
- PFS Nasdaq
- Market Cap
- PTGX 3.3B
- PFS 2.4B
- IPO Year
- PTGX 2016
- PFS N/A
- Fundamental
- Price
- PTGX $53.00
- PFS $18.64
- Analyst Decision
- PTGX Strong Buy
- PFS Strong Buy
- Analyst Count
- PTGX 9
- PFS 5
- Target Price
- PTGX $67.11
- PFS $23.60
- AVG Volume (30 Days)
- PTGX 923.4K
- PFS 666.6K
- Earning Date
- PTGX 08-05-2025
- PFS 07-24-2025
- Dividend Yield
- PTGX N/A
- PFS 5.17%
- EPS Growth
- PTGX N/A
- PFS N/A
- EPS
- PTGX 0.86
- PFS 1.19
- Revenue
- PTGX $207,801,000.00
- PFS $700,486,000.00
- Revenue This Year
- PTGX N/A
- PFS $26.03
- Revenue Next Year
- PTGX $53.09
- PFS $7.82
- P/E Ratio
- PTGX $61.48
- PFS $15.61
- Revenue Growth
- PTGX N/A
- PFS 58.68
- 52 Week Low
- PTGX $32.50
- PFS $14.34
- 52 Week High
- PTGX $60.60
- PFS $22.24
- Technical
- Relative Strength Index (RSI)
- PTGX 53.99
- PFS 64.68
- Support Level
- PTGX $49.38
- PFS $17.40
- Resistance Level
- PTGX $51.51
- PFS $18.93
- Average True Range (ATR)
- PTGX 2.02
- PFS 0.47
- MACD
- PTGX -0.39
- PFS 0.13
- Stochastic Oscillator
- PTGX 46.09
- PFS 86.72
About PTGX Protagonist Therapeutics Inc.
Protagonist Therapeutics Inc is a clinical-stage biopharmaceutical company having a proprietary technology platform that enables the discovery and development of novel constrained peptide-based drug candidates to address medical needs. Its pipeline products include Rusfertide (PTG-300) and JNJ-2113.
About PFS Provident Financial Services Inc
Provident Financial Services Inc is the holding company for The Provident Bank, a community-oriented bank. The Company's operations are solely in the financial services industry and include providing traditional banking and other financial services to its customers. The Company operates in the geographical regions of northern and central New Jersey, Queens and Nassau Counties in New York and eastern Pennsylvania. The Company has a single reporting segment for financial reporting purposes. The majority of the revenue-generating activities that are components of non-interest income are These revenue streams can generally be classified into three broad categories: wealth management revenue, insurance agency income, and banking service charges and other fees.